
    
      This trial is designed to assess the efficacy, safety and tolerability of flexible dose
      brexpiprazole as monotherapy or as combination therapy with Zoloft (Sertraline) in adult
      subjects with PTSD.

      This study will consist of a continuous 12-week, double-blind treatment period with a 14-day
      follow-up.
    
  